Modelling ischemia-reperfusion injury (IRI) in vitro using metabolically matured induced pluripotent stem cell-derived cardiomyocytes
Coronary intervention following ST-segment elevation myocardial infarction (STEMI) is the treatment of choice for reducing cardiomyocyte death but paradoxically leads to reperfusion injury. Pharmacological post-conditioning is an attractive approach to minimize Ischemia-Reperfusion Injury (IRI), but...
Main Authors: | Alejandro Hidalgo, Nick Glass, Dmitry Ovchinnikov, Seung-Kwon Yang, Xinli Zhang, Stuart Mazzone, Chen Chen, Ernst Wolvetang, Justin Cooper-White |
---|---|
Format: | Article |
Language: | English |
Published: |
AIP Publishing LLC
2018-06-01
|
Series: | APL Bioengineering |
Online Access: | http://dx.doi.org/10.1063/1.5000746 |
Similar Items
-
Opportunities and Limitations of Modelling Alzheimer’s Disease with Induced Pluripotent Stem Cells
by: Dmitry A. Ovchinnikov, et al.
Published: (2014-12-01) -
Cardioprotective Effects of Quercetin in Cardiomyocyte under Ischemia/Reperfusion Injury
by: Yi-Wen Chen, et al.
Published: (2013-01-01) -
Differentation and maturation of pluripotent stem cell-derived cardiomyocytes
by: Kolker, Ljudmila
Published: (2013) -
Targeting MIAT reduces apoptosis of cardiomyocytes after ischemia/reperfusion injury
by: Longying Chen, et al.
Published: (2019-01-01) -
Effects of Agarwood Extract on Cardiomyocyte in the Ischemia/Reperfusion Injury Model
by: Yu-Lin Chang, et al.
Published: (2019)